Use access key #2 to skip to page content.
$43.56 1.11 (2.61%)
5/16/2008 4:01 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

1

Avatar KingPortu (80.99) Submitted: 10/29/07 2:34 PM : Underperform Start Price: $46.93 AZN Score: -0.11

I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off

Report this Post Replies: 0 | Reply

Featured Broker Partners